Take Action!

Learn More!

Get on the mailing lists for Physicians for a National Health Program, Families USA, and the Kaiser Family Foundation so that you can stay up to date on what is happening in Washington!

Endorse a National Single-Payer Health Plan

Your organization can endorse a national single-payer health plan. You can print a form from the PNHP website and forward this to your representative and Senators.

Ask your representatives to introduce the "Uninsured Americans Protection Act".

When I was running for congress last year, I published a simple proposal to help protect Americans who do not have health insurance from unscrupulous fees:

Any healthcare provider or facility which receives government reimbursement for services must make available by request and online a list of all services and procedures done, what they charge, and what Medicare reimburses for the same service.
No health care facility which receives government reimbursement for services may charge an uninsured "captive patient" - that is, a patient admitted to the Emergency Room, observation status, or inpatient status - more than 30% above Medicare rates for services rendered.

Very few insurance companies pay more than 30% above Medicare, so this would be fair to both providers and patients.

Ask your representatives to introduce the "Pharmaceutical Competitiveness Act"

When I was a congressional candidate, I proposed an act to restore competition and bring down prices in the pharmaceutical industry:

First - new products in an established class of medications will get shorter patent protection unless they are priced significantly lower in price than the existing drugs in that class.
Any medication that increases more in price each year than a reasonable rate determined by the FDA (based on increasing production costs only) will lose its patent protection one year earlier for each year of excessive price increase.
Old drugs that are "reinvented" into time-release products (such as Ambien and Ambien CR), that are remarketed as a metabolite of an existing drug (Nexium is a metabolic breakdown product of Prilosec), or that are split into stereoisomers (desloratadine/Clarinex versus loratadine/Claritin) are not new agents and will receive minimal patent protection.
Secret kickbacks from pharmaceutical companies to health insurance companies through third-party intermediaries (“PBM’s”, or pharmacy benefit management companies) which are currently standard practice, are monopolistic, anticompetitive, and violations of anti-racketeering laws. This legislation will include these arrangements in the classification of illegal kickbacks, and force the pharmaceutical companies to set one wholesale price for each product. Pharmacies could then offer competitive prices to all customers.

Contacting your representatives:

You can get contact information for your representatives in Washington through Congress.org